Public Release Summary on the evaluation of the new active zilpaterol hydrochloride in the product Zilmax Medicated Premix

This consultation closed on 23 June 2020.
Consultation period: 
19 May 2020 to 23 June 2020
At the request of stakeholders, we have extended the consultation closing date to 23 June 2020.

The APVMA is assessing an application for approval of the new active constituent zilpaterol hydrochloride and registration of the product Zilmax Medicated Premix, containing 48 g/kg zilpaterol hydrochloride. The product is proposed to be used for increased carcass leanness, increased dressing percent, improved rate of body weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 20 days on feed. 

We invite comment from 19 May 2020 to 23 June 2020 on whether approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds, including:

  • chemistry and manufacture
  • occupational health and safety
  • public health
  • environmental safety
  • residues in food
  • trade
  • efficacy and target animal safety.

Download the Public Release Summary on the evaluation of Zilmax Medicated Premix.

For more information see page 25, APVMA Gazette No. 10, 19 May 2020

Please send your written submission by email or post to:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Phone: +61 2 6770 2300
Email: enquiries@apvma.gov.au.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.